within Pharmacolibrary.Drugs.D_Dermatologicals.D07A_CorticosteroidsPlain.D07AB19_Dexamethasone;

model Dexamethasone_1
  extends Pharmacolibrary.Drugs.ATC.D.D07AB19_1;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>D07AB19_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Dexamethasone is a potent synthetic member of the glucocorticoid class of steroid drugs. It is used as an anti-inflammatory and immunosuppressant in conditions such as allergies, asthma, rheumatoid arthritis, severe COVID-19, various cancers, and cerebral edema. Dexamethasone is approved and widely used both in hospital and outpatient settings.</p><h4>Pharmacokinetics</h4><p>PK parameters for intravenous bolus administration in healthy adults.</p><h4>References</h4><ol><li><p>Czock, D, et al., &amp; Häussler, U (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. <i>Clinical pharmacokinetics</i> 44(1) 61–98. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200544010-00003&quot;>10.2165/00003088-200544010-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15634032/&quot;>https://pubmed.ncbi.nlm.nih.gov/15634032</a></p></li><li><p>Nijstad, AL, et al., &amp; Zwaan, CM (2022). Overestimation of the effect of (fos)aprepitant on intravenous dexamethasone pharmacokinetics requires adaptation of the guidelines for children with chemotherapy-induced nausea and vomiting. <i>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</i> 30(12) 9991–9999. DOI:<a href=&quot;https://doi.org/10.1007/s00520-022-07423-6&quot;>10.1007/s00520-022-07423-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36287279/&quot;>https://pubmed.ncbi.nlm.nih.gov/36287279</a></p></li><li><p>Valtari, A, et al., &amp; Amo, EMD (2024). Comprehensive ocular and systemic pharmacokinetics of dexamethasone after subconjunctival and intravenous injections in rabbits. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 198 114260–None. DOI:<a href=&quot;https://doi.org/10.1016/j.ejpb.2024.114260&quot;>10.1016/j.ejpb.2024.114260</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38484852/&quot;>https://pubmed.ncbi.nlm.nih.gov/38484852</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Dexamethasone_1;
